Literature DB >> 24820082

Molecular epidemiology of KPC-producing Escherichia coli: occurrence of ST131-fimH30 subclone harboring pKpQIL-like IncFIIk plasmid.

Jessica A O'Hara1, Fupin Hu2, Chulsoo Ahn1, Jeremy Nelson1, Jesabel I Rivera1, Anthony W Pasculle3, Yohei Doi4.   

Abstract

Of 20 Klebsiella pneumoniae carbapenemase (KPC)-producing Escherichia coli isolates identified at hospitals in western Pennsylvania, 60% belonged to the epidemic ST131-fimH30 subclone. IncFIIk was the most common replicon type for the blaKPC-carrying plasmids (n = 8). All IncFIIk plasmids possessed a scaffold similar to that of pKpQIL, and seven of them were borne by ST131-fimH30 isolates. IncN plasmids conferred resistance to trimethoprim-sulfamethoxazole, and IncA/C plasmids conferred resistance to gentamicin. Three blaKPC-carrying plasmids (IncA/C and IncN) possessed blaSHV-7/12 and qnrA1 or qnrS1.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24820082      PMCID: PMC4068586          DOI: 10.1128/AAC.02182-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

1.  Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel.

Authors:  Shiri Navon-Venezia; Inna Chmelnitsky; Azita Leavitt; Mitchell J Schwaber; David Schwartz; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

2.  Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000-2004).

Authors:  Lalitagauri M Deshpande; Ronald N Jones; Thomas R Fritsche; Helio S Sader
Journal:  Microb Drug Resist       Date:  2006       Impact factor: 3.431

3.  First report on a hyperepidemic clone of KPC-3-producing Klebsiella pneumoniae in Israel genetically related to a strain causing outbreaks in the United States.

Authors:  Shiri Navon-Venezia; Azita Leavitt; Mitchell J Schwaber; J Kamile Rasheed; Arjun Srinivasan; Jean B Patel; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2008-11-24       Impact factor: 5.191

4.  Reduced susceptibility to cefepime among Escherichia coli clinical isolates producing novel variants of CMY-2 beta-lactamase.

Authors:  Yohei Doi; David L Paterson; Jennifer M Adams-Haduch; Hanna E Sidjabat; Alexandra O'Keefe; Andrea Endimiani; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2009-05-04       Impact factor: 5.191

5.  Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel.

Authors:  Azita Leavitt; Yehuda Carmeli; Inna Chmelnitsky; Moran G Goren; Itzhak Ofek; Shiri Navon-Venezia
Journal:  Antimicrob Agents Chemother       Date:  2010-03-29       Impact factor: 5.191

6.  When carbapenem-hydrolyzing beta-lactamase Kpc meets Escherichia coli ST131 in France.

Authors:  Thierry Naas; Gaelle Cuzon; Olivier Gaillot; René Courcol; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2011-07-18       Impact factor: 5.191

Review 7.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

8.  Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008.

Authors:  Moran G Goren; Shiri Navon-Venezia; Inna Chmelnitsky; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2010-03-15       Impact factor: 5.191

9.  Characterization of plasmids harbouring qnrS1, qnrB2 and qnrB19 genes in Salmonella.

Authors:  Aurora García-Fernández; Daniela Fortini; Kees Veldman; Dik Mevius; Alessandra Carattoli
Journal:  J Antimicrob Chemother       Date:  2008-11-11       Impact factor: 5.790

10.  Sex and virulence in Escherichia coli: an evolutionary perspective.

Authors:  Thierry Wirth; Daniel Falush; Ruiting Lan; Frances Colles; Patience Mensa; Lothar H Wieler; Helge Karch; Peter R Reeves; Martin C J Maiden; Howard Ochman; Mark Achtman
Journal:  Mol Microbiol       Date:  2006-06       Impact factor: 3.501

View more
  21 in total

Review 1.  The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae.

Authors:  Amy J Mathers; Gisele Peirano; Johann D D Pitout
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

2.  Variation in resistance traits, phylogenetic backgrounds, and virulence genotypes among Escherichia coli clinical isolates from adjacent hospital campuses serving distinct patient populations.

Authors:  Sarah M Drawz; Stephen Porter; Michael A Kuskowski; Brian Johnston; Connie Clabots; Susan Kline; Patricia Ferrieri; James R Johnson
Journal:  Antimicrob Agents Chemother       Date:  2015-06-22       Impact factor: 5.191

3.  KPC-Like Carbapenemase-Producing Enterobacteriaceae Colonizing Patients in Europe and Israel.

Authors:  A Baraniak; R Izdebski; J Fiett; M Herda; L P G Derde; M J M Bonten; A Adler; Y Carmeli; H Goossens; W Hryniewicz; C Brun-Buisson; M Gniadkowski
Journal:  Antimicrob Agents Chemother       Date:  2015-12-28       Impact factor: 5.191

4.  Development of a Web Tool for Escherichia coli Subtyping Based on fimH Alleles.

Authors:  Louise Roer; Veronika Tchesnokova; Rosa Allesøe; Mariya Muradova; Sujay Chattopadhyay; Johanne Ahrenfeldt; Martin C F Thomsen; Ole Lund; Frank Hansen; Anette M Hammerum; Evgeni Sokurenko; Henrik Hasman
Journal:  J Clin Microbiol       Date:  2017-06-07       Impact factor: 5.948

5.  Dominance of IMP-4-producing enterobacter cloacae among carbapenemase-producing Enterobacteriaceae in Australia.

Authors:  Hanna E Sidjabat; Nicola Townell; Graeme R Nimmo; Narelle M George; Jennifer Robson; Renu Vohra; Louise Davis; Claire Heney; David L Paterson
Journal:  Antimicrob Agents Chemother       Date:  2015-04-27       Impact factor: 5.191

Review 6.  Carbapenemase-producing Enterobacteriaceae.

Authors:  Yohei Doi; David L Paterson
Journal:  Semin Respir Crit Care Med       Date:  2015-02-02       Impact factor: 3.119

7.  Microbiological features of KPC-producing Enterobacter isolates identified in a U.S. hospital system.

Authors:  Chulsoo Ahn; Alveena Syed; Fupin Hu; Jessica A O'Hara; Jesabel I Rivera; Yohei Doi
Journal:  Diagn Microbiol Infect Dis       Date:  2014-06-23       Impact factor: 2.803

8.  Global incidence of carbapenemase-producing Escherichia coli ST131.

Authors:  Gisele Peirano; Patricia A Bradford; Krystyna M Kazmierczak; Robert E Badal; Meredith Hackel; Daryl J Hoban; Johann D D Pitout
Journal:  Emerg Infect Dis       Date:  2014-11       Impact factor: 6.883

Review 9.  Therapy of Infections due to Carbapenem-Resistant Gram-Negative Pathogens.

Authors:  Chang-Seop Lee; Yohei Doi
Journal:  Infect Chemother       Date:  2014-09-24

10.  Molecular characterization of a multidrug resistance IncF plasmid from the globally disseminated Escherichia coli ST131 clone.

Authors:  Minh Duy Phan; Brian M Forde; Kate M Peters; Sohinee Sarkar; Steven Hancock; Mitchell Stanton-Cook; Nouri L Ben Zakour; Mathew Upton; Scott A Beatson; Mark A Schembri
Journal:  PLoS One       Date:  2015-04-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.